Pulling SEC filings + quote and writing the call…

ASSURANT, INC.
Next earnings Aug 3, 2026 · consensus $5.24 EPS, $3.47B rev
Last earnings +3.5% on 2026-05-05
Specialty insurer compounding double-digit EPS at a reasonable 15x, with rising cash flow, ROE near 15% and steady capital returns.
Revenue $12.8B · FY2025
Quality fundamentals and an attractive price line up (~55% below fair value) — the rarer case where both the business and the entry look good.
Assurant is a specialty insurer (lifestyle and housing protection products) that has delivered four consecutive years of rising earnings, and FY2025 was another strong step: revenue grew 7.9% to $12.8B, net income rose 14.8% to $873M, and diluted EPS jumped 17.1% to $16.93 — outpacing net income thanks to a 2.2% reduction in the share count. Return on equity of 14.9% is healthy for an insurer, and stockholders' equity grew 15.0% to $5.87B, reflecting strong internal capital generation.
Cash generation underpins the quality. Operating cash flow surged 37.6% to $1.83B against modest $236M of capex, comfortably funding $304M of buybacks and $168M of dividends (the dividend up 8.0%). The recovery in profitability is notable against the lumpy FY2022 ($277M net income), showing the franchise has restored consistent earnings power. Management confirmed internal controls were effective with a clean PwC audit, and the balance sheet leverage (liabilities/equity 5.18x) is typical for an insurance carrier whose liabilities are largely policy reserves rather than financial debt.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:47 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $10.2B | $10.2B | $11.1B | $11.9B | $12.8B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $1.36B | $277M | $643M | $760M | $873M |
| Diluted EPS | $22.66 | $5.05 | $11.95 | $14.46 | $16.93 |
| Net margin | 13.4% | 2.7% | 5.8% | 6.4% | 6.8% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001267238, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/21/2026, 8:47:15 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 2 sales
| 2026-06-22 | Lonergan Robert EVP, CSTO | Sell | 7.00K @ $262.71 | $1.84M |
| 2026-05-26 | DiRienzo Dimitry SVP, CAO, Controller | Sell | 2.00K @ $255.68 | $511K |
| 2026-05-22 | Basu Rajiv Director | Award | 668.00 | |
| 2026-05-22 | Blake Lynn S. Director | Award | 668.00 | |
| 2026-05-22 | Carter J Braxton II Director | Award | 668.00 | |
| 2026-05-22 | EDELMAN HARRIET Director | Award | 668.00 | |
| 2026-05-22 | Granat Sari Beth Director | Award | 668.00 | |
| 2026-05-22 | Redzic Ognjen Director | Award | 668.00 |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1 buy · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.